Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,292
Closed -$1.51M 81
2026
Q1
$1.51M Buy
+4,292
New +$1.53M 0.24% 87
2025
Q4
Sell
-4,292
Closed -$1.21M 44
2025
Q3
$1.21M Buy
+4,292
New +$1.24M 0.16% 92
2025
Q2
Sell
-4,292
Closed -$1.32M 167
2025
Q1
$1.32M Hold
4,292
0.2% 67
2024
Q4
$1.12M Hold
4,292
0.17% 90
2024
Q3
$1.38M Hold
4,292
0.23% 63
2024
Q2
$1.34M Hold
4,292
0.22% 64
2024
Q1
$1.22M Hold
4,292
0.22% 68
2023
Q4
$1.33M Hold
4,292
0.65% 42
2023
Q3
$1.14M Hold
4,292
0.23% 61
2023
Q2
$966K Buy
+4,292
New +$996K 0.21% 66
2023
Q1
Sell
-4,292
Closed -$1.13M 148
2022
Q4
$1.13M Hold
4,292
0.43% 45
2022
Q3
$991K Hold
4,292
0.24% 62
2022
Q2
$1.05M Hold
4,292
0.23% 66
2022
Q1
$1.04M Hold
4,292
0.2% 82
2021
Q4
$964K Hold
4,292
0.17% 92
2021
Q3
$900K Hold
4,292
0.16% 100
2021
Q2
$1.05M Hold
4,292
0.2% 94
2021
Q1
$1.06M Hold
4,292
0.23% 84
2020
Q4
$1.02M Hold
4,292
0.23% 78
2020
Q3
$1.03M Buy
4,292
+2,267
+112% +$562K 0.28% 73
2020
Q2
$517K Hold
2,025
0.25% 52
2020
Q1
$416K Sell
2,025
-13,475
-87% -$2.94M 0.41% 57
2019
Q4
$3.72M Buy
15,500
+5,500
+55% +$1.21M 0.85% 25
2019
Q3
$1.91M Hold
10,000
0.46% 56
2019
Q2
$1.85M Buy
+10,000
New +$1.79M 0.48% 51

Other funds holding AMGN

Sanders Morris Harris's AMGN Position: Q2 2026 in Review

Sanders Morris Harris sold out of Amgen (AMGN) in Q2 2026, closing a stake of 4,292 shares — an estimated $1.51M sold.

Sanders Morris Harris first reported a position in AMGN in Q2 2019 and held it in 25 quarters. The position peaked at $3.72M in Q4 2019. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sanders Morris Harris reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Sanders Morris Harris sold 4,292 Amgen shares in Q2 2026, an estimated $1.51M.
  • Sanders Morris Harris first reported a position in Amgen in Q2 2019 and held it in 25 quarters.
  • Sanders Morris Harris's Amgen position peaked at $3.72M in Q4 2019.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.